Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Spectrum Pharmaceuticals, Inc. - Common Stock (NQ:SPPI)

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Jul 31, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Spectrum Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Spectrum Pharmaceuticals Stockholders Vote “FOR” Proposed Transaction with Assertio Holdings, Inc.
From Spectrum Pharmaceuticals, Inc.
Via Business Wire
SPECTRUM PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Spectrum Pharmaceuticals, Inc. - SPPI
From Kahn Swick & Foti, LLC
Via Business Wire
Are (More) Big Gains Ahead for This Small Cap Biotech Stock?
With Biomea Fusion's share price nearly halved recently, oversold conditions seem to be setting in. This could be an opportunity for small cap growth investors. 
Via MarketBeat
Topics Initial Public Offering
Expert Ratings for Spectrum Pharma
Via Benzinga
Why Semtech Shares Are Trading Higher By 25%; Here Are 20 Stocks Moving Premarket
Gainers Airspan Networks Holdings Inc. (NYSE: MIMO) shares rose 50.5% to $0.20 in pre-market trading after dropping 5% on Wednesday. 
Via Benzinga
Spectrum Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement
From Spectrum Pharmaceuticals, Inc.
Via Business Wire
Undervalued Biotech Stocks to Watch After Enzolytics’ (OTC:ENZC) 300% Run: RMED, SPPI, HALB, VXRT
Via AB Newswire
Spectrum Pharma: Q1 Earnings Insights
Spectrum Pharma (NASDAQ:SPPI) reported its Q1 earnings results on Tuesday, May 9, 2023 at 07:00 AM. Here's what investors need to know about the announcement. Earnings Spectrum Pharma beat estimated... 
Via Benzinga
Spectrum Pharmaceuticals Reports First Quarter 2023 Financial Results and Corporate Update
From Spectrum Pharmaceuticals, Inc.
Via Business Wire
7 A-Rated Stocks to Buy for May 2023
This is no time to "sell in May and go away." You'll never get the power of compounding interest that way. Find some stocks to buy instead. 
Via InvestorPlace
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Spectrum Pharmaceuticals, Inc. (Nasdaq – SPPI), BELLUS Health Inc (Nasdaq – BLU), Prometheus Biosciences, Inc. (Nasdaq – RXDX), Univar Solutions Inc. (NYSE - UNVR)
From Brodsky & Smith LLC
Via GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For April 26, 2023
Via Benzinga
SPECTRUM PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Spectrum Pharmaceuticals, Inc. - SPPI
From Kahn Swick & Foti, LLC
Via Business Wire
Dow Dips Over 300 Points; McDonald's Beats Q1 Expectations
U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping over 300 points on Tuesday. The Dow traded down 0.92% to 33,562.53 while the NASDAQ fell 1.75% to 11,826.47. The S&P 500,... 
Via Benzinga
Why GE HealthCare Technologies Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Spectrum Pharmaceuticals, Inc. (Nasdaq – SPPI), BELLUS Health Inc (Nasdaq – BLU), Prometheus Biosciences, Inc. (Nasdaq – RXDX), Univar Solutions Inc. (NYSE – UNVR)
From Brodsky & Smith LLC
Via GlobeNewswire
Assertio Scoops Up Spectrum Pharma In $248M Stock Deal
Assertio Holdings Inc (NASDAQ: ASRT) will acquire Spectrum Pharmaceuticals Inc (NASDAQ: SPPI) in an all-stock and contingent value rights (CVR) transaction. 
Via Benzinga
SPPI Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Spectrum Pharmaceuticals, Inc. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
What Is Going on With In8bio (INAB) Stock Today?
In8bio (INAB) stock is on the move Tuesday as investors react to a recent rally and additional news from the biotechnology company. 
Via InvestorPlace
Why Is TRACON Pharma (TCON) Stock Down 51% Today?
TRACON Pharmaceuticals (TCON) stock is falling on Tuesday morning following an update on a legal battle with I-Mab (IMAB). 
Via InvestorPlace
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Why Is Vyant Bio (VYNT) Stock Down 35% Today?
Vyant Bio (VYNT) stock is taking a beating on Tuesday after the biotechnology company announced plans to delist its shares. 
Via InvestorPlace
Why Is Spectrum Pharmaceuticals (SPPI) Stock Up 35% Today?
Spectrum Pharmaceuticals (SPPI) stock is soaring higher on Tuesday thanks to a $291 million acquisition deal with Assertio (ASRT). 
Via InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
It's time for another dive into the biggest pre-market stock movers as we check out the latest news worth watching on Tuesday! 
Via InvestorPlace
Why Chicken Soup For The Soul Entertainment Shares Are Trading Higher By 14%; Here Are 20 Stocks Moving Premarket
Gainers RiceBran Technologies (NASDAQ: RIBT) gained 43.1% to $1.33 in pre-market trading after gaining 3% on Tuesday. 
Via Benzinga
10 Best Performing Penny Stocks In The Healthcare Sector
As with any other sector, not all healthcare penny stocks encounter success. In fact, most don’t do that well. Yet those that win often earn massive returns for investors. Here's a look at the 10 best... 
Via Talk Markets
NASDAQ:SPPI Long Term Shareholder Alert: Investigation over Possible Wrongdoing at Spectrum Pharmaceuticals, Inc.
San Diego, CA -- (SBWIRE) -- 03/23/2023 -- Certain directors of Spectrum Pharmaceuticals, Inc. are under investigation over potential breaches of fiduciary duties. 
Via SBWire
Spectrum Pharmaceuticals Reports Fourth Quarter 2022 and Full Year 2022 Financial Results and Corporate Update
From Spectrum Pharmaceuticals, Inc.
Via Business Wire
Earnings Scheduled For March 22, 2023
Companies Reporting Before The Bell • Boyd Gaming (NYSE:BYD) is estimated to report quarterly earnings at $1.09 per share on revenue of $848.27 million. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.